The NanoMedicines Innovation Network (NMIN) is advancing “smart” medicines to cure disease by delivering small molecule drugs more specifically to disease sites and enabling the clinical use of gene therapies. NMIN brings investigators from universities across Canada—a multidisciplinary collective of physicists, engineers, chemists, biochemists, cell biologists, disease specialists, and clinicians—together with companies and not-for-profit research and granting institutions to expand and improve Canada’s position as world leader in nanomedicines R&D. NMIN invests in projects aimed at developing new therapeutics and diagnostics. Particular efforts are made to conduct projects partnered with industry to ensure market impact. NMIN is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.